top of page
VIEW DETAILS
Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea
No.
4
작성자:
이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang
[논문] 이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang, Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea , HAEMOPHILIA (Jan, 2021)
이한길, Ah-Young Kim, Deborah Baik, Hyeonseok Cho, Jung Woo Han, Minjun Lee, Seonyoung Park, Hye-Young Kang
bottom of page